David Klonoff to Pandemics
This is a "connection" page, showing publications David Klonoff has written about Pandemics.
Connection Strength
0.193
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Eur Rev Med Pharmacol Sci. 2021 02; 25(3):1663-1669.
Score: 0.031
-
Hospital Diabetes Meeting 2020. J Diabetes Sci Technol. 2020 09; 14(5):928-944.
Score: 0.030
-
The Coronavirus 2019 Pandemic and Diabetes: An International Perspective. J Diabetes Sci Technol. 2020 07; 14(4):703-704.
Score: 0.030
-
Telemedicine for Diabetes After the COVID-19 Pandemic: We Can't Put the Toothpaste Back in the Tube or Turn Back the Clock. J Diabetes Sci Technol. 2020 Jul; 14(4):741-742.
Score: 0.030
-
Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity. Metabolism. 2020 07; 108:154224.
Score: 0.029
-
Effect of Environmental Pollutants PM2.5, CO, NO2, and O3 on the Incidence and Mortality of SARS-CoV-2 Infection in Five Regions of the USA. Int J Environ Res Public Health. 2021 Jul 23; 18(15).
Score: 0.008
-
How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit. J Diabetes Sci Technol. 2021 03; 15(2):478-514.
Score: 0.008
-
Impact of lockdown on COVID-19 prevalence and mortality during 2020 pandemic: observational analysis of 27 countries. Eur J Med Res. 2020 Nov 10; 25(1):56.
Score: 0.008
-
Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline. J Diabetes Sci Technol. 2020 11; 14(6):1035-1064.
Score: 0.008
-
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. J Diabetes Sci Technol. 2020 Jul; 14(4):813-821.
Score: 0.007
-
ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation. Eur J Endocrinol. 2020 Aug; 183(2):G67-G77.
Score: 0.002
-
Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic. J Diabetes Sci Technol. 2020 Jul; 14(4):822-832.
Score: 0.002
-
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. Eur Rev Med Pharmacol Sci. 2020 04; 24(8):4539-4547.
Score: 0.002